6-[F-18]fluorodopamine positron emission tomographic scanning in the assessment of cardiac sympathoneural function

被引:44
作者
Goldstein, DS [1 ]
Holmes, C [1 ]
Stuhlmuller, JE [1 ]
Lenders, JWM [1 ]
Kopin, IJ [1 ]
机构
[1] NINCDS,CLIN NEUROSCI BRANCH,NIH,BETHESDA,MD 20892
关键词
fluorodopamine; sympathetic; trimethaphan; desipramine; tyramine;
D O I
10.1007/BF02267622
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Thoracic positron emission tomographic (PET) scanning after injection of 6-[F-18]fluorodopamine ([F-18]-6F-DA) visualizes cardiac sympathetic innervation We tested whether changes in curves relating myocardial [F-18]-6F-DA-derived radioactivity with time (time-activity curves, TACs) can reflect changes in important aspects of cardiac sympathetic function. Thoracic PET scans were obtained after intravenous administration of [F-18]-6F-DA or the perfusion imaging agent [N-13]ammonia into normal volunteers. Ganglion blockade with trimethaphan (TRI) was used to decrease sympathoneural traffic, desipramine (DMI) to block neuronal uptake of catecholamines, and tyramine (TYR) to displace vesicular amines. After [F-18]-6F-DA administration, myocardial concentrations of [F-18]-6F-DA-derived radioactivity declined bi-exponentially from the peak value. TRI increased the y-intercept (y(o)) value for the early phase (p = 0.01), and DMI decreased the y(o) for the late phase (p = 0.01). The TRI effect did not result from increased arterial [F-18]-6F-DA concentrations or from increased myocardial perfusion. TYR infusion, begun 90 min after [F-18]-6F-DA administration, accelerated the decline of myocardial radioactivity by 2.6-fold (p = 0.003). Alterations in post-ganglionic sympathoneural traffic, neuronal catecholamine uptake, and vesicular turnover of monoamines produce distinct changes in myocardial TACs after [F-18]-6F-DA injection. [F-18]-6F-DA PET scanning may therefore enable assessments of effects of stressors, drugs, and neurocardiological disorders on specific aspects of cardiac sympathoneural function.
引用
收藏
页码:17 / 29
页数:13
相关论文
共 36 条
  • [1] CHANG PC, 1990, J PHARMACOL EXP THER, V255, P809
  • [2] CHIUEH CC, 1983, J PHARMACOL EXP THER, V225, P529
  • [3] RENAL SYMPATHETIC-NERVE ACTIVITY AND NOREPINEPHRINE RELEASE IN RATS
    DEKASTAROSTA, A
    GARTY, M
    ZUKOWSKAGROJEC, Z
    KEISER, HR
    KOPIN, IJ
    GOLDSTEIN, DS
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1989, 257 (01): : R229 - R236
  • [4] DING YS, 1993, J NUCL MED, V34, P619
  • [5] DUNN BB, 1991, NUCL MED BIOL, V18, P209
  • [6] SYMPATHETIC NERVOUS FUNCTION IN HUMAN HEART AS ASSESSED BY CARDIAC SPILLOVERS OF DIHYDROXYPHENYLGLYCOL AND NOREPINEPHRINE
    EISENHOFER, G
    ESLER, MD
    MEREDITH, IT
    DART, A
    CANNON, RO
    QUYYUMI, AA
    LAMBERT, G
    CHIN, J
    JENNINGS, GL
    GOLDSTEIN, DS
    [J]. CIRCULATION, 1992, 85 (05) : 1775 - 1785
  • [7] EISENHOFER G, 1989, J PHARMACOL EXP THER, V248, P419
  • [8] NORADRENALINE REUPTAKE AND PLASMA DIHYDROXYPHENYLGLYCOL DURING SUSTAINED CHANGES IN SYMPATHETIC ACTIVITY IN RABBITS
    EISENHOFER, G
    COX, HS
    ESLER, MD
    [J]. JOURNAL OF THE AUTONOMIC NERVOUS SYSTEM, 1991, 32 (03): : 217 - 232
  • [9] CENTRAL SYMPATHOINHIBITION AND PERIPHERAL NEURONAL UPTAKE BLOCKADE AFTER DESIPRAMINE IN RABBITS
    EISENHOFER, G
    SAIGUSA, T
    ESLER, MD
    COX, HS
    ANGUS, JA
    DORWARD, PK
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1991, 260 (04): : R824 - R832
  • [10] SOURCE AND PHYSIOLOGICAL SIGNIFICANCE OF PLASMA 3,4-DIHYDROXYPHENYLGLYCOL AND 3-METHOXY-4-HYDROXYPHENYLGLYCOL
    EISENHOFER, G
    GOLDSTEIN, DS
    ROPCHAK, TG
    NGUYEN, HQ
    KEISER, HR
    KOPIN, IJ
    [J]. JOURNAL OF THE AUTONOMIC NERVOUS SYSTEM, 1988, 24 (1-2): : 1 - 14